IDiyas

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Richard Desmond

USPTO Granted Patents = 10

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Highland Park, NJ (US) (1989)
  • Metuchen, NJ (US) (1989 - 1995)
  • Bridgewater, NJ (US) (1996 - 2004)

Company Filing History:

goldMedal10 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1989-2004

Loading Chart...
10 patents (USPTO):
1. 6835837 - Process for making substituted 8-arylquinolinium benzenesulfonate (2004-12-28),
2. 5840924 - Process of preparing phenyl heterocycles useful as COX-2 inhibitors (1998-11-24),
3. 5585504 - Process of making cox-2 inhibitors having a lactone bridge (1996-12-17),
4. 5484923 - Process of making spirocycles and analogs thereof (1996-01-16),
5. 5446158 - Process for synthesis of FK-506 and tricarbonyl intermediates (1995-08-29),
6. 5155228 - FK-506 C10-C18 process intermediates (1992-10-13),
7. 4940797 - Process for synthesis of FK-506 C10-C18 intermediates (1990-07-10),
8. 4914220 - Process for synthesis of E-2-methyl-.alpha.,.beta.-unsaturated aldehydes (1990-04-03),
9. 4871873 - Process for synthesis of arylglyoxal arylimines (1989-10-03),
10. 4835276 - Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 (1989-05-30),

Title: Richard Desmond: Innovator in Pharmaceutical Chemistry

Introduction

Richard Desmond is a prominent inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on developing innovative processes for synthesizing compounds that have important medical applications.

Latest Patents

Among his latest patents is a process for making substituted 8-arylquinolinium benzenesulfonate. This invention involves the synthesis of a substituted 8-aryl quinoline and its benzenesulfonic acid salt. Another notable patent is for a process of preparing phenyl heterocycles useful as COX-2 inhibitors. This invention encompasses a process for making compounds that are beneficial in the treatment of inflammation and other cyclooxygenase-2 mediated diseases.

Career Highlights

Richard Desmond is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to the development of innovative pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Richard has collaborated with notable colleagues, including Sander G. Mills and David M. Tschaen. These collaborations have further enhanced the impact of his inventions in the pharmaceutical industry.

Conclusion

Richard Desmond's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…